Gabelli Funds’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Gabelli Funds’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-154,861	Closed	-$5.95M	–	1181
2023 Q2	$5.95M	Buy	+154,861	New	+$3.98M	0.05%	419

Gabelli Funds's KDNY Position: Q3 2023 in Review

Gabelli Funds sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 154,861 shares — an estimated $5.95M sold.

Gabelli Funds first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $5.95M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Gabelli Funds reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Gabelli Funds sold 154,861 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $5.95M.
Gabelli Funds first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Gabelli Funds's Chinook Therapeutics, Inc. Common Stock position peaked at $5.95M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Gabelli Funds's 13F filing for Q3 2023, filed 8 Nov 2023.